Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod in Rheumatoid Arthritis and Early Rheumatoid Arthritis in China
NCT03855007Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2016
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iguratimod in rheumatoid arthritis (RA), sponsored by Qilu Hospital of Shandong University. Started Jan 2016; status: completed.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03855007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855007.